Urinary podocalyxin as an early biomarker for diabetic nephropathy
PLOS One · 23.07.2026 · 21 (7) · e0347975
DOI: 10.1371/journal.pone.0347975 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 23.07.2026. Verfasst von Md Sabbir Hossain und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Sialoglycoproteins, Diabetes Mellitus, Type 2. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BSMMU grant committee.
Abstract (Originalsprache)
Background
Conventional biomarkers, such as the urinary albumin-to-creatinine ratio (uACR), detect diabetic nephropathy (DN) late in its course and may miss early podocyte injury. Urinary podocalyxin (u-PDX), a sialylated glycoprotein shed from podocytes, may offer an earlier means of detection.
Methods
We conducted a cross-sectional analytical study at Bangabandhu Sheikh Mujib Medical University between March 2023 and August 2024. Eighty-eight adults were enrolled: 59 participants with type 2 diabetes mellitus (T2DM) and 29 healthy controls. Participants with diabetes were stratified into normoalbuminuric (n = 29), microalbuminuric (n = 15), and macroalbuminuric (n = 15) subgroups based on uACR. Clinical variables and biochemical indices were recorded. u-PDX concentrations were measured using ELISA, and associations with uACR and eGFR were analyzed using Kendall’s tau-b and Pearson’s correlation coefficients. Diagnostic performance was assessed using receiver operating characteristic (ROC) curves with bootstrap internal validation.
Results
Among participants with diabetes, u-PDX levels increased progressively across normo-, micro-, and macroalbuminuric groups (p < 0.001). u-PDX correlated positively with fasting blood glucose, post-glucose plasma glucose, HbA1c, serum creatinine, serum urea, and uACR, with the strongest correlation for uACR (r = 0.79, p < 0.001), and inversely with serum albumin (r = −0.62, p < 0.001) and eGFR (r = −0.51, p < 0.001). In pairwise ROC analysis, a u-PDX cutoff of 0.80 ng/mL discriminated healthy controls from diabetic patients without albuminuria (sensitivity 100.0%, specificity 96.4%); 1.60 ng/mL discriminated diabetic patients without albuminuria from those with microalbuminuria (86.7%, 93.1%); and 5.51 ng/mL discriminated microalbuminuric from macroalbuminuric patients (86.7%, 93.3%). For overall discrimination of albuminuria-defined DN among diabetic patients, the optimal u-PDX cutoff was 2.92 ng/mL (AUC 0.96, 95% CI 0.90–1.00).
Conclusions
Urinary podocalyxin is a sensitive early biomarker of diabetic nephropathy, rising before overt albuminuria and correlating with albuminuria severity and declining eGFR. However, longitudinal validation is required before u-PDX can be recommended for routine screening in adults with T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
- National Institute of Cardiovascular Diseases, Dhaka, Bangladesh.
ORCID-Profile: Kazi Ali Aftab, Abdullah Al Mahdi, Md Abul Kalam Azad
Förderung
- BSMMU grant committee
Zitieren
APA
Hossain, M. S., Dwipi, S. T., Ahmed, N., Murshed, K. M., Aftab, K. A., Al Mahdi, A., Hoque, M. M., Taraq, M. J. H., Hussain, M. Z., & Azad, M. A. K. (2026). Urinary podocalyxin as an early biomarker for diabetic nephropathy. PLOS One, 21(7), e0347975. https://doi.org/10.1371/journal.pone.0347975
Vancouver
Hossain MS, Dwipi ST, Ahmed N, Murshed KM, Aftab KA, Al Mahdi A, et al. Urinary podocalyxin as an early biomarker for diabetic nephropathy. PLOS One. 2026;21(7):e0347975. doi:10.1371/journal.pone.0347975
BibTeX
@article{Hossain2026,
author = {Hossain, Md Sabbir and Dwipi, Shamsia Tasnim and Ahmed, Nazma and Murshed, Khaled Mahbub and Aftab, Kazi Ali and Al Mahdi, Abdullah and Hoque, Md Mojibul and Taraq, Md Jobayer Hossain and Hussain, Md Zakir and Azad, Md Abul Kalam},
title = {Urinary podocalyxin as an early biomarker for diabetic nephropathy},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0347975},
doi = {10.1371/journal.pone.0347975}
}
EUVIMED